Status:
COMPLETED
Novel Application of Simulation for Providers to Overcome Decisional Gaps in High-risk Prescribing
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Ideas42
National Institute on Aging (NIA)
Conditions:
Medication Administered in Error
Antipsychotics and Neuroleptics Toxicity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This pilot project aims to reduce the prescribing of high-risk medications, such as antipsychotics and benzodiazepines, to hospitalized older adults. To accomplish this, this project consists of two p...
Detailed Description
The overarching goal is to determine whether a newly-designed simulation-based training program for providers based on underlying principles of System 1 and System 2 thinking reduces prescribing of hi...
Eligibility Criteria
Inclusion
- Residents and interns at Brigham and Women's Hospital will be eligible for this trial if they care for older adults (age 65+) admitted to one of the general medicine wards during an evening shift.
Exclusion
Key Trial Info
Start Date :
March 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT04668248
Start Date
March 29 2021
End Date
December 31 2021
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02120